|
|
Volumn 33, Issue SUPPL. 3, 2001, Pages
|
|
Should we reevaluate antibiotic breakpoints?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
BETA LACTAM ANTIBIOTIC;
CEPHALOSPORIN DERIVATIVE;
OXACILLIN;
PENICILLIN G;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
VANCOMYCIN;
ANTIBIOTIC BIOSYNTHESIS;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
AREA UNDER THE CURVE;
BACTERIAL INFECTION;
CHROMOSOME BREAKAGE;
CONFERENCE PAPER;
DRUG FORMULATION;
HUMAN;
MINIMUM INHIBITORY CONCENTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
STRAIN DIFFERENCE;
ANTI-BACTERIAL AGENTS;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
|
|
EID: 0035885032
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/321852 Document Type: Conference Paper |
|
Times cited : (29)
|
|
References (4)
|
